Connecticut Innovations has launched a campaign to highlight the growing companies, top talent, cutting-edge research, and quality of life in Connecticut’s life sciences ecosystem.
Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and a primary source of financing and ongoing support for the state’s innovative, growing companies, has launched efforts to promote Connecticut’s life sciences ecosystem. The campaign is being conducted in partnership with AdvanceCT and BioCT, according to a Feb. 11, 2021 press release.
The campaign, known as “Connecticut: Where Science Lives,” highlights the life sciences opportunities in Connecticut and is intended to attract new businesses to the state, while supporting existing businesses. The campaign was designed by Primacy, a full-service digital experience agency located in Farmington, CT, and includes a dedicated website; traditional, digital and out of home advertising; and social media outreach. The effort was prompted by state legislation passed in 2018 to position Connecticut as a leader in life sciences.
The state has seen a surge of activity in the life sciences sector from the growth of companies like Sema4 and Arvinas; a $200-million, 14-story, 513,000-ft2, Leadership in Energy and Environmental Design-certified office space and life sciences incubator in New Haven, CT; and the COVID-related successes from Pfizer, CI said in the press release.
“Connecticut has become a nucleus of life science advancement, and companies of all sizes are taking maximum advantage of intellectual capital, talent, and practical expertise to be found here,” said Dawn Hocevar, president and CEO of BioCT, a nonprofit organization dedicated to supporting and growing bioscience in Connecticut, in the press release. “Startup activity is at a high; we are seeing record investment and expansion within the ecosystem, and several new commercial developments are underway to deliver increased lab space and resources in the near future.”
“Through the Connecticut Bioscience Innovation Fund (CBIF), we are seeing more investment opportunities in life sciences than ever before,” said Matt McCooe, CEO of Connecticut Innovations, in the press release. “The hope is that this campaign highlights what most of us who live here already know—companies can succeed here because of access to capital, resources, and top talent, which are essential for growth.”
“The Where Science Lives campaign is consistent with our mission to engage, retain, and recruit businesses to our state,” said Peter Denious, president and CEO of AdvanceCT, in the press release. “Life sciences is one of our key industries in Connecticut, and this campaign highlights our value proposition for employers and industry professionals. We look forward to making new connections and helping interested employers and talent learn more about the life—and the science—in our great state.”
Source: Connecticut Innovations
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.